Foundation date



#Biotechnology / R&D Services


Therapeutic areas

ImmuneSpec offers MHC associated peptide proteomics (MAPPS) as a service. We developed an advanced immunopeptidomics platform which allows fast & reliable identification of immunogenic peptides to pinpoint all peptide regions which evoke an immune response. Key applications include pinpointing immunogenic areas for the development of broad-spectrum vaccines, identification of neo-antigens for the generation of leads suitable for immunotherapy, and testing of biologics for unwanted immunogenicity.

Upcoming events

Latest news

  • argenx reports topline results from ADVANCE-SC study of VYVGART Hytrulo in primary immune thrombocytopenia

    19 hours ago

  • Biocartis Holdings Inc.: Recapitalization completed and product portfolio expansion

    Wednesday November 22nd 2023

  • argenx announces European Commission approval of subcutaneous VYVGART® (efgartigimod alfa) for generalized myasthenia gravis

    Thursday November 16th 2023